NRXP

NRx Pharmaceuticals, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Javitt Jonathan CDirector, 10 Percent Owner, Officer: Chairman And Chief Scientist
$47k40k shares
BuyDec 17, 2024
$1.17
--

News

globenewswire.comNRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.globenewswire.comJun 5globenewswire.comNRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters' Optionglobenewswire.comJun 4globenewswire.comNRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stockglobenewswire.comJun 3globenewswire.comNRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stockglobenewswire.comJun 2globenewswire.comNRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validation of the EMOCARE Depression Thermometer at ASCP 2026globenewswire.comMay 28